The efficacy and safety of shortand long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial - Best, PJ; Steinhubl, SR; Berger, PB (Am Heart J, 2008)
et al.